Showing results (71-80 of 934) with videos related to
Sort By:
Pageof 94
The Journal of Allergy and Clinical Immunology|July 15, 2022
Allosteric inhibition of SHP2 rescues functional T-cell abnormalities in SAP deficiencyNeelam Panchal, Benjamin Christopher Houghton, Elina Vassalou, et al.The Journal of Clinical Investigation|April 7, 2009
Preventing and exploiting the oncogenic potential of integrating gene vectorsUte Modlich, Christopher BaumThe Hematology Journal : the Official Journal of the European Haematology Association|March 30, 2004
Gene therapy for inherited disorders of haematopoietic cellsChristoph Klein, Christopher BaumCurrent Opinion in Molecular Therapeutics|November 7, 2003
Mutagenesis by retroviral transgene insertion: risk assessment and potential alternativesChristopher Baum, Boris FehseDNA Repair|May 8, 2007
Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cellsAxel Schambach, Christopher BaumCurrent Gene Therapy|December 17, 2008
Clinical application of lentiviral vectors - concepts and practiceAxel Schambach, Christopher BaumExperimental Hematology|May 2, 2006
Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical researchAxel Schambach, Melanie Galla, Ute Modlich, et al.Cancer Immunology, Immunotherapy : CII|February 24, 2007
Development of anti-PAX3 immune responses; a target for cancer immunotherapyNourredine Himoudi, Steven Nabarro, Mengyong Yan, et al.Clinical Science (London, England : 1979)|February 7, 2003
Gene therapy for ocular angiogenesisJames W B Bainbridge, Ajay R Mistry, Adrian J Thrasher, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Bone marrow-derived IFN-producing killer dendritic cells account for the tumoricidal activity of unpulsed dendritic cellsNourredine Himoudi, Stephen Nabarro, Jo Buddle, et al.Pageof 94